Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | PRKCA | P17252 | 7/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | KDM1A | O60341 | 2/20 | 0.56 |
| ▸ | BACE1 | P56817 | 1/20 | 0.56 |
| ▸ | SNCA | P37840 | 1/20 | 0.54 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL546757 | 1.00 | GAA (0.65) | GAATDP1PRKCAHSP90AA1CYP19A1 | |
| SCHEMBL31487400 | 1.00 | GAA (0.65) | GAATDP1PRKCAHSP90AA1CYP19A1 | |
| SCHEMBL30669730 | 1.00 | GAA (0.65) | GAATDP1PRKCAHSP90AA1CYP19A1 | |
| SCHEMBL15711523 | 1.00 | GAA (0.65) | GAATDP1PRKCAHSP90AA1CYP19A1 | |
| SCHEMBL15147273 | 1.00 | GAA (0.65) | GAATDP1PRKCAHSP90AA1CYP19A1 | |
| SCHEMBL3986428 | 1.00 | GAA (0.65) | GAATDP1PRKCAHSP90AA1CYP19A1 | |
| SCHEMBL15144478 | 1.00 | GAA (0.65) | GAATDP1PRKCAHSP90AA1CYP19A1 | |
| SCHEMBL29531507 | 1.00 | GAA (0.65) | GAATDP1PRKCAHSP90AA1CYP19A1 | |
| SCHEMBL9234208 | 0.90 | SNCA (0.54) | GAATDP1PRKCAHSP90AA1CYP19A1 | |
| SCHEMBL9231411 | 0.90 | SNCA (0.54) | GAATDP1PRKCAHSP90AA1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118177317-A | Functional dry noodle leaf for diabetics and preparation method thereof | 河南工业大学 | 2024-06-14 | — | — | CN | claimed |
| US-9381223-B2 | Methods for inhibiting advanced glycation end product production, inhibiting fibroblast apoptosis, and/or promoting human fibroblast-collagen grating formulation using cherry blossom and cherry leaf extract | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2016-07-05 | — | — | US | claimed |
| US-20150174188-A1 | METHODS FOR INHIBITING ADVANCED GLYCATION END PRODUCT PRODUCTION, INHIBITING FIBROBLAST APOPTOSIS, AND/OR PROMOTING HUMAN FIBROBLAST-COLLAGEN GRATING FORMULATION USING CHERRY BLOSSOM AND CHERRY LEAF EXTRACT | ORYZA OIL & FAT CHEM (JP) | 2015-06-25 | — | — | US | claimed |
| US-20130196937-A1 | AGE PRODUCTION INHIBITOR | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2013-08-01 | — | — | US | claimed |
| CN-118177317-A | Functional dry noodle leaf for diabetics and preparation method thereof | 河南工业大学 | 2024-06-14 | — | — | CN | disclosed |
| CN-116987807-A | SNP molecular marker related to polyphenol content of tomato fruits and application thereof | 中国农业大学 | 2023-11-03 | — | — | CN | disclosed |
| CN-106061461-B | oral biofilm calcification inhibitor and oral composition | 狮王株式会社 | 2019-02-15 | — | — | CN | disclosed |
| US-9381223-B2 | Methods for inhibiting advanced glycation end product production, inhibiting fibroblast apoptosis, and/or promoting human fibroblast-collagen grating formulation using cherry blossom and cherry leaf extract | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2016-07-05 | — | — | US | disclosed |
| US-9381223-B2 | Methods for inhibiting advanced glycation end product production, inhibiting fibroblast apoptosis, and/or promoting human fibroblast-collagen grating formulation using cherry blossom and cherry leaf extract | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2016-07-05 | — | — | US | disclosed |
| US-20150174188-A1 | METHODS FOR INHIBITING ADVANCED GLYCATION END PRODUCT PRODUCTION, INHIBITING FIBROBLAST APOPTOSIS, AND/OR PROMOTING HUMAN FIBROBLAST-COLLAGEN GRATING FORMULATION USING CHERRY BLOSSOM AND CHERRY LEAF EXTRACT | ORYZA OIL & FAT CHEM (JP) | 2015-06-25 | — | — | US | disclosed |
| US-20150174188-A1 | METHODS FOR INHIBITING ADVANCED GLYCATION END PRODUCT PRODUCTION, INHIBITING FIBROBLAST APOPTOSIS, AND/OR PROMOTING HUMAN FIBROBLAST-COLLAGEN GRATING FORMULATION USING CHERRY BLOSSOM AND CHERRY LEAF EXTRACT | ORYZA OIL & FAT CHEM (JP) | 2015-06-25 | — | — | US | disclosed |
| CN-102883733-B | AGE production inhibitor | ORYZA OIL & FAT CHEM | 2014-08-13 | — | — | CN | disclosed |
| US-20130196937-A1 | AGE PRODUCTION INHIBITOR | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2013-08-01 | — | — | US | disclosed |
| US-20130196937-A1 | AGE PRODUCTION INHIBITOR | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2013-08-01 | — | — | US | disclosed |
| CN-102883733-A | AGE production inhibitor | ORYZA OIL & FAT CHEM | 2013-01-16 | — | — | CN | disclosed |
| WO-2011099570-A1 | AGE PRODUCTION INHIBITOR | オリザ油化株式会社 (JP) | 2011-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130196937-A1 | AGE PRODUCTION INHIBITOR | AGER, GLA, GBA3 | GAA 5/4885TDP1 2159/4885PRKCA 1873/4885 |
| US-20150174188-A1 | METHODS FOR INHIBITING ADVANCED GLYCATION END PRODUCT PRODUCTION, INHIBITING FIBROBLAST APOPTOSIS, AND/OR PROMOTING HUMAN FIBROBLAST-COLLAGEN GRATING FORMULATION USING CHERRY BLOSSOM AND CHERRY LEAF EXTRACT | AGER, GLA, COLGALT1 | GAA 51/4885TDP1 1748/4885PRKCA 2525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.